PHASE I/II STUDY OF NC-6004, A NOVEL MICELLAR FORMULATION OF CISPLATIN, IN COMBINATION WITH GEMCITABINE IN PATIENTS WITH PANCREATIC CANCER IN ASIA - RESULTS OF PHASE I

被引：0
|
作者：
Su, W. [1 ]
Chen, L. [1 ]
Li, C. [2 ]
Chen, J. [3 ]
Lin, Y. [4 ]
Choo, S. [5 ]
Matsumura, Y. [6 ]
机构：
[1] Natl Cheng Kung Univ Hosp, Tainan 70428, Taiwan
[2] Taipei Vet Gen Hosp, Taipei, Taiwan
[3] Chang Gung Mem Hosp, Taipei 10591, Taiwan
[4] Natl Taiwan Univ Hosp, Taipei, Taiwan
[5] Natl Canc Ctr Singapore, Singapore, Singapore
[6] Natl Canc Ctr Hosp E, Kashiwa, Chiba, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：247 / 247
页数：1
相关论文
共 50 条
  • [21] A multicenter phase I/II study of gemcitabine and personalized peptide vaccination combination therapy for metastatic pancreatic cancer patients
    Yanagmoto, H.
    Satoi, S.
    Mine, T.
    Tanaka, K.
    Yamada, A.
    Oka, M.
    Itoh, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [22] Phase I/II study of mocetinostat in combination with gemcitabine for patients with advanced pancreatic cancer and other advanced solid tumors
    Chan, Emily
    Chiorean, E. Gabriela
    O'Dwyer, Peter J.
    Gabrail, Nashat Y.
    Alcindor, Thierry
    Potvin, Diane
    Chao, Richard
    Hurwitz, Herbert
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (02) : 355 - 364
  • [23] Phase I/II study of mocetinostat in combination with gemcitabine for patients with advanced pancreatic cancer and other advanced solid tumors
    Emily Chan
    E. Gabriela Chiorean
    Peter J. O’Dwyer
    Nashat Y. Gabrail
    Thierry Alcindor
    Diane Potvin
    Richard Chao
    Herbert Hurwitz
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 355 - 364
  • [24] A pilot phase I/II study of combination chemotherapy with nafamostat mesilate and gemcitabine for unresectable pancreatic cancer
    Uwagawa, T.
    Misawa, T.
    Iida, T.
    Matsumoto, M.
    Gocho, T.
    Hirohara, S.
    Sadaoka, S.
    Yanaga, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [25] Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer
    R D Kim
    S R Alberts
    C Peña
    I Genvresse
    A Ajavon-Hartmann
    C Xia
    A Kelly
    J E Grilley-Olson
    British Journal of Cancer, 2018, 118 : 462 - 470
  • [26] A phase I/II study of combination chemotherapy with gemcitabine and 5-fluorouracil for advanced pancreatic cancer
    Okusaka, Takuji
    Ishii, Hiroshi
    Funakoshi, Akihiro
    Ueno, Hideki
    Furuse, Junji
    Sumii, Toshihiko
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 36 (09) : 557 - 563
  • [27] Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer
    Kim, R. D.
    Alberts, S. R.
    Pena, C.
    Genvresse, I.
    Ajavon-Hartmann, A.
    Xia, C.
    Kelly, A.
    Grilley-Olson, J. E.
    BRITISH JOURNAL OF CANCER, 2018, 118 (04) : 462 - 470
  • [28] A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancer
    Hwang, In Gyu
    Jang, Joung-Soon
    Oh, Sung Yong
    Lee, Suee
    Kwon, Hyuk Chan
    Lee, Gyeong Won
    Go, Seil
    Kang, Myoung Hee
    Cha, Young Joo
    Kang, Jung Hun
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (06) : 2371 - 2376
  • [29] A Phase II Trial of Erlotinib in Combination With Gemcitabine and Cisplatin for Unresectable Pancreatic Cancer
    Hwang, I. G.
    Jang, J. S.
    Kang, J. H.
    Lee, G. W.
    Go, S. I.
    Kang, M. H.
    Oh, S. Y.
    Lee, S.
    Kwon, H. C.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S461 - S461
  • [30] A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancer
    In Gyu Hwang
    Joung-Soon Jang
    Sung Yong Oh
    Suee Lee
    Hyuk Chan Kwon
    Gyeong Won Lee
    Seil Go
    Myoung Hee Kang
    Young Joo Cha
    Jung Hun Kang
    Investigational New Drugs, 2012, 30 : 2371 - 2376
12345